合成毒品3-MMC近年来在美国和欧洲的舞蹈俱乐部中日益流行[1]。这种由以色列化学家Dr. Zee开发的物质因成本低廉、药效持久和成瘾性强等特点吸引使用者用于派对狂欢和提高工作效率[1]。尽管3-MMC已于2022年在欧盟和2023年在美国被列为管制物质[1]，其供应链依然稳定，源头可追溯至中国和印度的工业实验室[1]。
在医学研究领域，多家制药公司正在探索3-MMC的治疗潜力。制药公司Definium Therapeutics正在研究该物质用于心理治疗和创伤后应激障碍（PTSD）的治疗[1]。Period Pill公司进行的3-MMC基药物第一阶段研究显示，该物质有望缓解月经痛并改善情绪[1]。此外，Dr. Zee声称自己已长期服用3-MMC达10年之久[1]。
The synthetic drug 3-MMC has emerged as a popular substance in dance clubs across the United States and Europe, driven by its low cost, prolonged effects, and high addiction potential [1]. Developed by Israeli chemist Dr. Zee, the compound has gained traction among partygoers and individuals seeking performance enhancement [1]. Dr. Zee has claimed to consume 3-MMC daily for up to 10 years [1].
Authorities have moved to restrict the substance, with the European Union designating it as a controlled drug in 2022 and the United States following suit in 2023 [1]. However, the supply chain remains resilient, with industrial laboratories in China and India continuing to produce the substance [1]. Pharmaceutical companies have begun exploring medical applications for 3-MMC. Definium Therapeutics is investigating its potential for psychotherapy and post-traumatic stress disorder treatment, while Period Pill's 3-MMC-based drug showed potential in alleviating menstrual pain and improving mood during early-stage clinical trials [1].